ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 5 for:    mpex and cystic fibrosis
Previous Study | Return to List | Next Study

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01180634
Recruitment Status : Completed
First Posted : August 12, 2010
Last Update Posted : January 19, 2018
Sponsor:
Collaborator:
Forest Laboratories
Information provided by (Responsible Party):
Horizon Pharma USA, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : September 2012
  Certification/Extension First Submitted : January 17, 2018